BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1014 related articles for article (PubMed ID: 21927575)

  • 1. Diverse roles of TGF-β/Smads in renal fibrosis and inflammation.
    Lan HY
    Int J Biol Sci; 2011; 7(7):1056-67. PubMed ID: 21927575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.
    Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY
    Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smads as therapeutic targets for chronic kidney disease.
    Lan HY
    Kidney Res Clin Pract; 2012 Mar; 31(1):4-11. PubMed ID: 26889404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β/Smad signaling in kidney disease.
    Lan HY; Chung AC
    Semin Nephrol; 2012 May; 32(3):236-43. PubMed ID: 22835454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta and Smad signalling in kidney diseases.
    Wang W; Koka V; Lan HY
    Nephrology (Carlton); 2005 Feb; 10(1):48-56. PubMed ID: 15705182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-β/Smad signalling in diabetic nephropathy.
    Lan HY
    Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):731-8. PubMed ID: 22211842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the TGF-β/BMP-7/Smad pathways in renal diseases.
    Meng XM; Chung AC; Lan HY
    Clin Sci (Lond); 2013 Feb; 124(4):243-54. PubMed ID: 23126427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chrysophanol ameliorates renal interstitial fibrosis by inhibiting the TGF-β/Smad signaling pathway.
    Dou F; Ding Y; Wang C; Duan J; Wang W; Xu H; Zhao X; Wang J; Wen A
    Biochem Pharmacol; 2020 Oct; 180():114079. PubMed ID: 32511988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-β signalling in renal fibrosis: from Smads to non-coding RNAs.
    Tang PM; Zhang YY; Mak TS; Tang PC; Huang XR; Lan HY
    J Physiol; 2018 Aug; 596(16):3493-3503. PubMed ID: 29781524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad7 as a therapeutic agent for chronic kidney diseases.
    Lan HY
    Front Biosci; 2008 May; 13():4984-92. PubMed ID: 18508563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of Angiotensin-Converting Enzyme-2 Promotes Hypertensive Nephropathy by Targeting Smad7 for Ubiquitin Degradation.
    Liu Z; Huang XR; Chen HY; Fung E; Liu J; Lan HY
    Hypertension; 2017 Oct; 70(4):822-830. PubMed ID: 28808068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-β Mediates Renal Fibrosis via the Smad3-Erbb4-IR Long Noncoding RNA Axis.
    Feng M; Tang PM; Huang XR; Sun SF; You YK; Xiao J; Lv LL; Xu AP; Lan HY
    Mol Ther; 2018 Jan; 26(1):148-161. PubMed ID: 29102563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of Smad4 impairs TGF-β/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro.
    Meng XM; Huang XR; Xiao J; Chung AC; Qin W; Chen HY; Lan HY
    Kidney Int; 2012 Feb; 81(3):266-79. PubMed ID: 22048127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of Smad7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGF-β/Smad3-NF.κB-dependent mechanisms in mice.
    Liu GX; Li YQ; Huang XR; Wei L; Chen HY; Shi YJ; Heuchel RL; Lan HY
    PLoS One; 2013; 8(1):e53573. PubMed ID: 23301086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Smad signaling in kidney disease.
    Zhang Y; Wang S; Liu S; Li C; Wang J
    Int Urol Nephrol; 2015 Dec; 47(12):1965-75. PubMed ID: 26433882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3.
    Yang F; Chung AC; Huang XR; Lan HY
    Hypertension; 2009 Oct; 54(4):877-84. PubMed ID: 19667256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-β/Smad signaling in renal fibrosis.
    Meng XM; Tang PM; Li J; Lan HY
    Front Physiol; 2015; 6():82. PubMed ID: 25852569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
    Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
    Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diverse Role of TGF-β in Kidney Disease.
    Gu YY; Liu XS; Huang XR; Yu XQ; Lan HY
    Front Cell Dev Biol; 2020; 8():123. PubMed ID: 32258028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into TGF-β/Smad signaling in tissue fibrosis.
    Hu HH; Chen DQ; Wang YN; Feng YL; Cao G; Vaziri ND; Zhao YY
    Chem Biol Interact; 2018 Aug; 292():76-83. PubMed ID: 30017632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.